NCT05930964 is a clinical trial in Chronic Kidney Diseases, sponsored by Pardis Specialized Wellness Institute.

Who is sponsoring NCT05930964?

NCT05930964 is sponsored by Pardis Specialized Wellness Institute.

What condition does NCT05930964 study?

NCT05930964 studies Chronic Kidney Diseases, End Stage Renal Disease, Hemodialysis Complication.

Is NCT05930964 still recruiting?

NCT05930964 is currently completed. Last updated 18 November 2023.

Last reviewed 2023-11-18 · How we verify

NCT05930964

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validity of Low Physical Activity Questionnaire (LoPAQ)

Completed Last updated 18 November 2023

What this trial tests

trial in Chronic Kidney Diseases in 100 participants. Completed in 2 June 2023.

Timeline

26 April 2023

Primary endpoint
24 May 2023

2 June 2023

Quick facts

Lead sponsor	Pardis Specialized Wellness Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	100
Start date	26 April 2023
Primary completion	24 May 2023
Estimated completion	2 June 2023
Sites	1 location across Iran

Conditions studied

Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
End Stage Renal Disease — all drugs for End Stage Renal Disease →
Hemodialysis Complication — all drugs for Hemodialysis Complication →

Sponsor

Pardis Specialized Wellness Institute

Who can join

Adults 18 to 85, any sex, with Chronic Kidney Diseases or End Stage Renal Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to assess validity and reliability of Persian Version of Low Physical Activity Questionnaire. The main questions it mains to answer are: What is the level of physical activity in hemodialysis patients? Is Persian Version of Low Physical Activity Questionnaire, Valid to assess physical activity levels of dialysis patients? Is Persian Version of Low Physical Activity Questionnaire, reliable? Participants will answer 3 questionnaires and will do some functional tests.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Validity and reliability of Persian version of Low Physical Activity Questionnaire (LoPAQ).
Tabibi MA, Samouei R, Salimian N, Shahidi S, et al · · 2024 · cited 1× · PMID 38778292 · DOI 10.1186/s12882-024-03615-w
Validity and Reliability of Persian Version of Low Physical Activity Questionnaire (LoPAQ)
Tabibi MA, Samouei R, Salimian N, Shahidi S, et al · · 2024 · DOI 10.21203/rs.3.rs-4059669/v1

Verify or expand the search:

Other recruiting trials for Chronic Kidney Diseases

Currently open trials in the same condition.

NCT06593392 — Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus · Phase 2 · recruiting
NCT07358572 — Eye-Brain-Kidney in CKD · recruiting
NCT06463483 — Automated Insulin Delivery in Adults With Advanced Kidney Disease · NA · recruiting
NCT06927024 — Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD) · NA · recruiting
NCT07115953 — Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension · NA · recruiting

Other Pardis Specialized Wellness Institute trials

Trials by the same sponsor.

NCT07525973 — The Effect of Eye Exercises on Motor Performance, Balance, and Fall Risk in Parkinson's Disease · NA · not yet recruiting
NCT07264114 — Aquatic High-Intensity Interval Training for Parkinson's Disease · NA · active not recruiting
NCT07000006 — The Effect of Exercise on Low Back Pain in Peritoneal Dialysis Patients · NA · completed
NCT06958380 — Corrective Exercise and Rehabilitation in Fanconi Anemia: A Case Study · NA · completed
NCT06877962 — The Effect of Home-based Exercise on Postural Abnormalities · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05930964 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pardis Specialized Wellness Institute
Last refreshed: 18 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05930964.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing